Using non-invasive spinal stimulation to improve arm and hand function in children and young people with hemiplegic cerebral palsy.
Official title: The Effects of Transcutaneous Spinal Cord Stimulation on Upper Extremity Function in Children and Young People With Hemiplegic Cerebral Palsy
Run by University of Leeds · NCT07247812 · Data updated 2026-11-12
This project will test whether mild transcutaneous spinal cord stimulation combined with targeted arm and hand exercises helps improve upper-limb movement in young people (aged 12–21) with hemiplegic cerebral palsy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 21 Years |
| Sex | All |
| Enrollment | 18 (estimated) |
| Sponsor | University of Leeds Academic / other |
| Locations | 1 site (Leeds) |
| Status | Recruiting |
| Started | April 29, 2026 |
| Main results expected | September 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT07247812 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking boys or girls aged 12–21 with a diagnosis of hemiplegic cerebral palsy who have difficulties with hand function, can perform simple reaching or grasping tasks, are medically stable, and can attend two in-person sessions.
✕Probably not a fit
Those unlikely to benefit include people with other neurological diseases, uncontrolled high blood pressure, recent major surgery, uncontrolled seizures, or who cannot tolerate or do not have any voluntary upper-limb movement to practice with training.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a small randomized crossover feasibility study in which 18 participants aged 12–21 with hemiplegic cerebral palsy will each attend two sessions of upper-limb training. One session pairs 30 minutes of targeted arm and hand task training with transcutaneous spinal cord stimulation (tSCS) delivered via surface pads using a Digimer DS8R device, and the other session provides the same training without stimulation. The order of sessions is randomized, and each visit includes baseline and post-training assessments, with sessions lasting about 60–90 minutes. The study will compare immediate changes in motor performance between the stimulation and no-stimulation conditions to determine feasibility and preliminary effectiveness.
Why it matters
Potential benefit: If successful, this could provide a non-invasive adjunct to therapy that improves hand and arm control and helps young people with hemiplegic CP perform daily tasks more independently.
How similar studies have gone: Previous research has shown promising effects of tSCS for lower-limb function in children with cerebral palsy and in adults with spinal cord injury, but its use specifically for upper-limb improvement in hemiplegic CP is novel and limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Age and Gender: Boys and girls aged 12 to 21 years. * Diagnosis: Are diagnosed with Hemiplegic Cerebral Palsy (HCP). * Hand Function: Are experiencing difficulties with hand functions in daily activities. * Medical Stability: Have stable medical conditions without cardiopulmonary disease or seizures. * Motor Capability: Are capable of performing simple motor tasks such as reaching, touching, or grasping objects. * Availability: Are able to attend two sessions * Consent informed: Are able to provide informed consent (or if under 16, will need to have a parent or legal guardian who is willing to provide consent on their behalf). * Language: Are able to speak English (and if under 16, their parent or legal guardian must also be able to speak English) Exclusion Criteria * Other Neurological Conditions: Have neurological diseases other than cerebral palsy. * Blood Pressure: Have uncontrolled or high blood pressure. * Recent Surgeries: Have recently undergone significant surgeries (neurological, cardiac, respiratory, or metabolic) without sufficient recovery time. * Severe Diseases: Have cardiovascular or pulmonary diseases. * Medical Complications: Have ongoing medical complications such as unhealed fractures, contractures, or active infections or cancer. * Protocol Compliance: Are unable to follow study protocols safely. * Epilepsy History: Have a personal or family history of epilepsy. * Recent Injections: Have had botulinum toxin injections within the past six months. * Implanted Devices: Have implanted devices like pacemakers or baclofen pumps. * Exclusion of Participants with Recent Research Involvement: Participants who have taken part in any clinical research study within the last 3 months will be excluded.
Where it's running
-
University of Leeds
Leeds, United Kingdom Recruiting
Study contacts
- Study coordinator: Omar NAHHAS, PhD Candidate
- Email: Bsothn@leeds.ac.uk
- Phone: + 44 113 343 7267
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Improving Quality of Life for Metastatic Breast Cancer Patients
This project tests a new EORTC quality-of-life questionnaire module for adults with metastatic breast cancer to better measure their day-to-day well-being.
-
Structured physical activity program added to tezepelumab for adults with severe asthma
A 12-week program to help adults with severe asthma who start tezepelumab see if adding guided physical activity improves activity levels and chances of remission.
-
Growing Well: Understanding How Young Children Eat and Grow
This study tests what and how much food and drinks are typical for children 6 months to 5 years old and how these patterns relate to growth and dental health.
-
Personalising Myeloma Treatment Based on Initial Response and Fitness
This trial tests whether adjusting treatment after six months of the standard DRd therapy, based on a patient’s response and fitness, can improve outcomes for older, transplant-ineligible patients with myeloma.
-
How heart rate affects heart pumping strength in people with heart failure and diabetes
Researchers will test whether abnormal metabolism in the heart and skeletal muscle explains why people with heart failure, especially those with diabetes, do not increase heart pumping effectively when their heart rate rises.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.